Acute Symptoms of Drug Hypersensitivity (Urticaria, Angioedema, Anaphylaxis, Anaphylactic Shock)

Medical Clinics of North America

Volumn 94, Issue 4, 2010, Pages 691-710

  Limsuwan, Ticha ^a   Demoly, Pascal ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Anaphylactic shock; Anaphylaxis; Angioedema; Drug hypersensitivity; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ANAPHYLACTIC SHOCK; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; C1 INH DEFICIENCY; CLINICAL FEATURE; CONTACT URTICARIA; DERMOGRAPHISM; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; ENZYME DEFICIENCY; ERYTHEMA MULTIFORME; HUMAN; PERIORBITAL ANGIOEDEMA; PRIMARY MAST CELL DISORDER; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; URTICARIA; VASCULITIS;

ADRENERGIC AGONISTS; ANAPHYLAXIS; ANGIOEDEMA; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; DRUG TOXICITY; EPINEPHRINE; HUMANS; RISK FACTORS; SYMPATHOMIMETICS; URTICARIA;

EID: 77953680578     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2010.03.007     Document Type: Review

References (82)

1. Demoly P., and Hillaire-Buys D. Classification and epidemiology of hypersensitivity drug reactions. Immunol Allergy Clin North Am 24 3 (2004) 345-356 v.
2. Demoly P., and Bousquet J. Epidemiology of drug allergy. Curr Opin Allergy Clin Immunol 1 4 (2001) 305-310
3. Gomes E.R., and Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 5 4 (2005) 309-316
4. Johansson S.G., Hourihane J.O., Bousquet J., et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 56 9 (2001) 813-824
5. Demoly P. Anaphylactic reactions-value of skin and provocation tests. Toxicology 209 2 (2005) 221-223
6. Demoly P., and Bousquet J. Drug allergy diagnosis work up. Allergy 57 Suppl 72 (2002) 37-40
7. Champion R.H., Roberts S.O., Carpenter R.G., et al. Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 81 8 (1969) 588-597
8. Grattan C.E. The urticaria spectrum: recognition of clinical patterns can help management. Clin Exp Dermatol 29 3 (2004) 217-221
9. Muller B.A. Urticaria and angioedema: a practical approach. Am Fam Physician 69 5 (2004) 1123-1128
10. Zacharisen M.C. Pediatric urticaria and angioedema. Immunol Allergy Clin North Am 19 2 (1999) 363-382
11. Dibbern Jr. D.A., and Dreskin S.C. Urticaria and angioedema: an overview. Immunol Allergy Clin North Am 24 2 (2004) 141-162 v.
12. Zuberbier T. Urticaria. Allergy 58 12 (2003) 1224-1234
13. Kaplan A.P., and Greaves M.W. Angioedema. J Am Acad Dermatol 53 3 (2005) 373-388 quiz 89-92
14. Deacock S.J. An approach to the patient with urticaria. Clin Exp Immunol 153 2 (2008 Aug) 151-161
15. Grattan C.E. Urticaria, angio-oedema and anaphylaxis. Clin Med 2 1 (2002) 20-23
16. Brown A.F., McKinnon D., and Chu K. Emergency department anaphylaxis: A review of 142 patients in a single year. J Allergy Clin Immunol 108 5 (2001) 861-866
17. Greenberger P.A. Anaphylactic and anaphylactoid causes of angioedema. Immunol Allergy Clin North Am 26 4 (2006) 753-767
18. Krasnick J., Patterson R., and Meyers G.L. A fatality from idiopathic anaphylaxis. Ann Allergy Asthma Immunol 76 4 (1996) 376-378
19. Humphreys F., and Hunter J.A. The characteristics of urticaria in 390 patients. Br J Dermatol 138 4 (1998) 635-638
20. Auquier-Dunant A., Mockenhaupt M., Naldi L., et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 138 8 (2002) 1019-1024
21. Baxi S., and Dinakar C. Urticaria and angioedema. Immunol Allergy Clin North Am 25 2 (2005) 353-367 vii
22. Sampson H.A., Munoz-Furlong A., Campbell R.L., et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium. J Allergy Clin Immunol 117 2 (2006) 391-397
23. Simons F.E. Anaphylaxis: recent advances in assessment and treatment. J Allergy Clin Immunol 124 4 (2009) 625-636 [quiz: 37-8]
24. Lieberman P., Camargo Jr. C.A., Bohlke K., et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 97 5 (2006) 596-602
25. Helbling A., Hurni T., Mueller U.R., et al. Incidence of anaphylaxis with circulatory symptoms: a study over a 3-year period comprising 940,000 inhabitants of the Swiss Canton Bern. Clin Exp Allergy 34 2 (2004) 285-290
26. Kemp S.F., Lockey R.F., Wolf B.L., et al. Anaphylaxis. A review of 266 cases. Arch Intern Med 155 16 (1995) 1749-1754
27. Webb L.M., and Lieberman P. Anaphylaxis: a review of 601 cases. Ann Allergy Asthma Immunol 97 1 (2006) 39-43
28. Lieberman P.L. Anaphylaxis. In: Adkinson N.F., Busse W.W., Bochner B.S., et al. (Eds). Middleton's Allergy: principles and practice. 7th edition (2009), Elsevier, China 1027-1050
29. Bircher A.J. Drug-induced urticaria and angioedema caused by non-IgE mediated pathomechanisms. Eur J Dermatol 9 8 (1999) 657-663 [quiz: 63]
30. Laroche D., Aimone-Gastin I., Dubois F., et al. Mechanisms of severe, immediate reactions to iodinated contrast material. Radiology 209 1 (1998) 183-190
31. Limsuwan T., and Castells M.C. Outcomes and safety of rapid desensitization for chemotherapy hypersensitivity. Expert Opin Drug Saf 9 1 (2010) 39-53
32. Mortureux P., Leaute-Labreze C., Legrain-Lifermann V., et al. Acute urticaria in infancy and early childhood: a prospective study. Arch Dermatol 134 3 (1998) 319-323
33. Schuller D.E., and Elvey S.M. Acute urticaria associated with streptococcal infection. Pediatrics 65 3 (1980) 592-596
34. Sanchez-Borges M., Capriles-Hulett A., and Caballero-Fonseca F. NSAID-induced urticaria and angioedema: a reappraisal of its clinical management. Am J Clin Dermatol 3 9 (2002) 599-607
35. Asero R. Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders. Ann Allergy Asthma Immunol 82 6 (1999) 554-558
36. Sanchez-Borges M., and Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol 84 1 (2000) 101-106
37. Mastalerz L., Setkowicz M., Sanak M., et al. Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. J Allergy Clin Immunol 113 4 (2004) 771-775
38. Stevenson D.D., and Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 118 4 (2006) 773-786 [quiz: 87-8]
39. Szczeklik A., and Stevenson D.D. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111 5 (2003) 913-921 [quiz: 22]
40. Sanchez-Borges M., Caballero-Fonseca F., and Capriles-Hulett A. Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema. Ann Allergy Asthma Immunol 95 2 (2005 Aug) 154-158
41. Sanchez-Borges M., Caballero-Fonseca F., and Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol 94 1 (2005 Jan) 34-38
42. Settipane R.A., Schrank P.J., Simon R.A., et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol 96 4 (1995) 480-485
43. Leone R., Conforti A., Venegoni M., et al. Drug-induced anaphylaxis: case/non-case study based on an Italian pharmacovigilance database. Drug Saf 28 6 (2005) 547-556
44. Zuberbier T., Asero R., Bindslev-Jensen C., et al. EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 64 10 (2009) 1427-1443
45. Agostoni A., and Cicardi M. Drug-induced angioedema without urticaria. Drug Saf 24 8 (2001) 599-606
46. Kostis J.B., Kim H.J., Rusnak J., et al. Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165 14 (2005) 1637-1642
47. Sabroe R.A., and Black A.K. Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema. Br J Dermatol 136 2 (1997) 153-158
48. Warner K.K., Visconti J.A., and Tschampel M.M. Angiotensin II receptor blockers in patients with ACE inhibitor-induced angioedema. Ann Pharmacother 34 4 (2000) 526-528
49. Bluestein H.M., Hoover T.A., Banerji A.S., et al. Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department. Ann Allergy Asthma Immunol 103 6 (2009) 502-507
50. Fuchs S.A., Koopmans R.P., Guchelaar H.J., et al. Are angiotensin II receptor antagonists safe in patients with previous angiotensin-converting enzyme inhibitor-induced angioedema?. Hypertension 37 1 (2001) E1
51. Howes L.G., and Tran D. Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?. Drug Saf 25 2 (2002) 73-76
52. Quiralte J., Blanco C., Castillo R., et al. Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol 98 3 (1996) 678-685
53. Quiralte J., Blanco C., Delgado J., et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Investig Allergol Clin Immunol 17 3 (2007) 182-188
54. Zuraw B.L. Clinical practice. Hereditary angioedema. N Engl J Med 359 10 (2008) 1027-1036
55. Bork K., Wulff K., Hardt J., et al. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol 124 1 (2009) 129-134
56. Neugut A.I., Ghatak A.T., and Miller R.L. Anaphylaxis in the United States: an investigation into its epidemiology. Arch Intern Med 161 1 (2001) 15-21
57. Tang A.W. A practical guide to anaphylaxis. Am Fam Physician 68 7 (2003) 1325-1332
58. Demoly P., Messaad D., Sahla H., et al. Immediate hypersensitivity to ceftriaxone. Allergy 55 4 (2000) 418-419
59. Gibbs M.W., Kuczkowski K.M., and Benumof J.L. Complete recovery from prolonged cardio-pulmonary resuscitation following anaphylactic reaction to readministered intravenous cefazolin. Acta Anaesthesiol Scand 47 2 (2003) 230-232
60. Mertes P.M., Laxenaire M.C., and Alla F. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 99 3 (2003) 536-545
61. Novembre E., Mori F., Pucci N., et al. Cefaclor anaphylaxis in children. Allergy 64 8 (2009) 1233-1235
62. Romano A., Quaratino D., Venemalm L., et al. A case of IgE-mediated hypersensitivity to ceftriaxone. J Allergy Clin Immunol 104 5 (1999) 1113-1114
63. Warrington R.J., and McPhillips S. Independent anaphylaxis to cefazolin without allergy to other beta-lactam antibiotics. J Allergy Clin Immunol 98 2 (1996) 460-462
64. Berkes E.A. Anaphylactic and anaphylactoid reactions to aspirin and other NSAIDs. Clin Rev Allergy Immunol 24 2 (2003) 137-148
65. Himly M., Jahn-Schmid B., Pittertschatscher K., et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 111 4 (2003) 882-888
66. Bavbek S., Erkekol F.O., Dursun B., et al. Meloxicam-associated anaphylactic reaction. J Investig Allergol Clin Immunol 16 5 (2006) 317-320
67. Chamberlin K.W., and Silverman A.R. Celecoxib-associated anaphylaxis. Ann Pharmacother 43 4 (2009) 777-781
68. Fontaine C., Bousquet P.J., and Demoly P. Anaphylactic shock caused by a selective allergy to celecoxib, with no allergy to rofecoxib or sulfamethoxazole. J Allergy Clin Immunol 115 3 (2005) 633-634
69. Levy M.B., and Fink J.N. Anaphylaxis to celecoxib. Ann Allergy Asthma Immunol 87 1 (2001) 72-73
70. Brockow K., Romano A., Aberer W., et al. Reactions to iodinated contrast media-a European multicenter study. Allergy 64 2 (2009) 234-241
71. Beaudouin E., Kanny G., Morisset M., et al. Immediate hypersensitivity to chlorhexidine: literature review. Eur Ann Allergy Clin Immunol 36 4 (2004) 123-126
72. Mertes P.M., Malinovsky J.M., Mouton-Faivre C., et al. Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases. J Allergy Clin Immunol 122 2 (2008) 348-352
73. Kemp S.F., Lockey R.F., and Simons F.E. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 63 8 (2008) 1061-1070
74. Kemp S.F., and Lockey R.F. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110 3 (2002) 341-348
75. Mertes P.M., Laxenaire M.C., Lienhart A., et al. Reducing the risk of anaphylaxis during anaesthesia: guidelines for clinical practice. J Investig Allergol Clin Immunol 15 2 (2005) 91-101
76. Simons F.E. Advances in H1-antihistamines. N Engl J Med 351 21 (2004) 2203-2217
77. Lieberman P. Biphasic anaphylactic reactions. Ann Allergy Asthma Immunol 95 3 (2005) 217-226 [quiz: 26, 58]
78. Zuberbier T., Ifflander J., Semmler C., et al. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol 76 4 (1996) 295-297
79. Brockow K., Romano A., Blanca M., et al. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 57 1 (2002) 45-51
80. Romano A., Gaeta F., Valluzzi R.L., et al. Diagnosing hypersensitivity reactions to cephalosporins in children. Pediatrics 122 3 (2008) 521-527
81. Romano A., Gueant-Rodriguez R.M., Viola M., et al. Diagnosing immediate reactions to cephalosporins. Clin Exp Allergy 35 9 (2005) 1234-1242
82. Aberer W., Bircher A., Romano A., et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 58 9 (2003) 854-863